The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies

Author:

Blanco-González Alexandre123ORCID,Cabezón Alfonso12,Seco-González Alejandro12,Conde-Torres Daniel12,Antelo-Riveiro Paula12,Piñeiro Ángel2,Garcia-Fandino Rebeca1

Affiliation:

1. Department of Organic Chemistry, Center for Research in Biological Chemistry and Molecular Materials, University of Santiago de Compostela, CIQUS, 15705 Santiago de Compostela, Spain

2. Soft Matter & Molecular Biophysics Group, Department of Applied Physics, Faculty of Physics, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain

3. MD.USE Innovations S.L., Edificio Emprendia, 15782 Santiago de Compostela, Spain

Abstract

Artificial intelligence (AI) has the potential to revolutionize the drug discovery process, offering improved efficiency, accuracy, and speed. However, the successful application of AI is dependent on the availability of high-quality data, the addressing of ethical concerns, and the recognition of the limitations of AI-based approaches. In this article, the benefits, challenges, and drawbacks of AI in this field are reviewed, and possible strategies and approaches for overcoming the present obstacles are proposed. The use of data augmentation, explainable AI, and the integration of AI with traditional experimental methods, as well as the potential advantages of AI in pharmaceutical research, are also discussed. Overall, this review highlights the potential of AI in drug discovery and provides insights into the challenges and opportunities for realizing its potential in this field. Note from the human authors: This article was created to test the ability of ChatGPT, a chatbot based on the GPT-3.5 language model, in terms of assisting human authors in writing review articles. The text generated by the AI following our instructions (see Supporting Information) was used as a starting point, and its ability to automatically generate content was evaluated. After conducting a thorough review, the human authors practically rewrote the manuscript, striving to maintain a balance between the original proposal and the scientific criteria. The advantages and limitations of using AI for this purpose are discussed in the last section.

Funder

Spanish Agencia Estatal de Investigación (AEI) and the ERDF

Xunta de Galicia and the ERDF

Centro Singular de Investigación de Galicia

Ministerio de Ciencia, Innovación y Universidades for a “Ramón y Cajal” contract

Xunta de Galicia for a predoctoral contract

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Reference56 articles.

1. (2022, December 06). OpenAI. ChatGPT (Dec 6 Version) [Large Language Model]. Available online: https://chat.openai.com/chat.

2. (2022, December 06). Plagiarism Detector Software|Anti-Plagiarism Tools|Copyleaks. Available online: https://copyleaks.com.

3. Artificial intelligence in drug discovery and development;Paul;Drug Discov. Today,2021

4. Artificial intelligence: A powerful paradigm for scientific research;Xu;Innovation,2021

5. Zhuang, D., and Ibrahim, A.K. (2021). Deep learning for drug discovery: A study of identifying high efficacy drug compounds using a cascade transfer learning approach. Appl. Sci., 11.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3